213 related articles for article (PubMed ID: 17583678)
1. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1.
Fukada Y; Yasui K; Kitayama M; Doi K; Nakano T; Watanabe Y; Nakashima K
Brain Res; 2007 Jul; 1160():1-10. PubMed ID: 17583678
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of HSP27 in a transgenic model of ALS.
Vleminckx V; Van Damme P; Goffin K; Delye H; Van Den Bosch L; Robberecht W
J Neuropathol Exp Neurol; 2002 Nov; 61(11):968-74. PubMed ID: 12430713
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
5. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
7. Adherent monomer-misfolded SOD1.
Watanabe Y; Morita E; Fukada Y; Doi K; Yasui K; Kitayama M; Nakano T; Nakashima K
PLoS One; 2008; 3(10):e3497. PubMed ID: 18946506
[TBL] [Abstract][Full Text] [Related]
8. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
[TBL] [Abstract][Full Text] [Related]
10. Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice.
Maatkamp A; Vlug A; Haasdijk E; Troost D; French PJ; Jaarsma D
Eur J Neurosci; 2004 Jul; 20(1):14-28. PubMed ID: 15245475
[TBL] [Abstract][Full Text] [Related]
11. Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells.
Patel YJ; Payne Smith MD; de Belleroche J; Latchman DS
Brain Res Mol Brain Res; 2005 Apr; 134(2):256-74. PubMed ID: 15836922
[TBL] [Abstract][Full Text] [Related]
12. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.
Sharp PS; Akbar MT; Bouri S; Senda A; Joshi K; Chen HJ; Latchman DS; Wells DJ; de Belleroche J
Neurobiol Dis; 2008 Apr; 30(1):42-55. PubMed ID: 18255302
[TBL] [Abstract][Full Text] [Related]
14. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
15. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
16. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis.
Yoshihara T; Ishigaki S; Yamamoto M; Liang Y; Niwa J; Takeuchi H; Doyu M; Sobue G
J Neurochem; 2002 Jan; 80(1):158-67. PubMed ID: 11796754
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Almer G; Vukosavic S; Romero N; Przedborski S
J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
[TBL] [Abstract][Full Text] [Related]
19. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
[TBL] [Abstract][Full Text] [Related]
20. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.
Kudo LC; Parfenova L; Vi N; Lau K; Pomakian J; Valdmanis P; Rouleau GA; Vinters HV; Wiedau-Pazos M; Karsten SL
Hum Mol Genet; 2010 Aug; 19(16):3233-53. PubMed ID: 20530642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
